History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
We're Ready To Help
We're Ready To Help
Call us to schedule an appointment or contact us online

At Memorial Sloan-Kettering Cancer Center, our Upper Gastrointestinal Disease Management Team focuses on cancers of the esophagus, stomach, and pancreas, as well as neuroendocrine tumors and tumors of the small intestine. The team comprises some 30 physicians, including surgeons, medical oncologists, gastroenterologists, radiologists, radiation oncologists, and pathologists.

Leadership Role

Memorial Sloan-Kettering is one of the few National Cancer Institute-designated cancer centers with a specific program in treating cancers of the upper gastrointestinal tract, and our investigators have made many of the major advances in the treatment of these diseases. Memorial Sloan-Kettering is a leading member of the American College of Surgeons Oncology Group (ACOSOG) and the Radiation Therapy Oncology Group (RTOG), and an active member of the Cancer and Leukemia Group B (CALGB).

Our Publications
Our Publications
Visit PubMed for our journal articles

Through these cooperative groups, Memorial Sloan-Kettering is a leading participant in most of the national trials to improve the detection, treatment, and prevention of upper gastrointestinal cancers. One of our main areas of research focuses on the identification of novel therapeutic drugs and targets, as well as treatment modalities and programs to improve the care of patients with upper gastrointestinal malignancies.

Barrett's Esophagus Screening

We offer screening for patients with Barrett's esophagus, a precancerous condition of the esophagus that may be caused by the chronic, abnormal exposure of the esophagus to acid (in most cases, stomach acid).

The Leading Edge of Surgical Expertise

An active program in minimally invasive surgery is available for evaluation and treatment of many gastrointestinal cancers and precancerous conditions.

Our surgeons, among the world's most experienced in treating esophageal cancers, are often able to completely remove such tumors. When tumors cannot be removed, new laser techniques can rapidly relieve obstructions that may cause pain and disability in patients with esophageal and stomach cancers.

Find a Clinical Trial
Find a Clinical Trial
Find out about new research studies for esophageal cancer

Innovative Systemic Treatments

Having pioneered systemic therapy -- treatment applied to the entire body -- for esophageal cancers, Memorial Sloan-Kettering is working to develop better chemotherapy agents for use alone and in combination. We offer innovative, combined-modality treatments for esophageal cancer using new drug combinations plus radiation therapy both before and instead of surgery. And for patients with more advanced disease, we are studying new, targeted drug agents.


Last Updated: Aug. 13, 2003
PrintEmail This Page